GRI Partner Receives Third Frontier Funding
Girindus America, one of seven partners comprising UC's new
Genome Research Institute (GRI),
has received more than $1.1 million from the State of Ohio's Third Frontier Action Fund. Governor Bob Taft presented Girindus with their check Thursday, Oct. 23 during a ceremony at the Girindus building on Reading Road.
This Third Frontier funding will support the creation of a biomedical process facility focused on oligoneucleotide (synthetic RNA and DNA) production. Oligoneucleotide production could be key in the formation of potential therapeutics in the future. GRI will provide the research capabilities needed to validate the use of these newly created therapeutics.
"Its important for Ohio to be involved in the initial stages of the development of new therapeutics which have the potential to one day treat or even possibly cure diseases," said David Millhorn, PhD, director of UC's GRI. "This interaction between academic and private sector provides the best economic opportunities for the State of Ohio."
UC's GRI is a laboratory complex located on Galbraith Road in Reading, Ohio, focused on the study of the biological and genetic causes of some of the world's most prevalent diseases including obesity, heart disease and cancer. Unique partnerships with Wright State University, Cincinnati Children's Hospital Medical Center, Meridian Bioscience, Girindus America, Procter & Gamble Pharmaceuticals, the Air Force Research Lab and Acero, will aid in the translation of scientific research to the commercialization of drugs and diagnostics.
To learn more about Girindus America, visit
. To read Governor Bob Taft's official announcement, visit
.
Tags
Related Stories
UC students organize free health clinic happening July 11-12
July 10, 2026
The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.
Is speech-to-text AI really reliable?
July 10, 2026
UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.
Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week
July 9, 2026
Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.